Literature DB >> 19010625

Chemosurgery with trichloroacetic acid for allergic rhinitis: evaluation of the efficacy in terms of inhibition of Th2 cell infiltration.

Kazuo Yao1, Kentaro Sato, Daisuke Usui, Rika Kurihara, Makito Okamoto, Yoshiaki Iguchi, Koichiro Nishiyama.   

Abstract

OBJECTIVE: To examine local inhibition of Th2 cell infiltration as the basis for demonstrating the superior clinical effect of trichloroacetic acid (TCA) treatment for allergic rhinitis.
METHODS: Mirror-image sections of the inferior turbinate mucosae of both sides were obtained from 26 patients who underwent TCA treatment on one side because of the nasal anatomy status and who eventually underwent bilateral inferior turbinectomy because of failure of the TCA treatment. Th2 cell counts, defined as counts of cells positive for anti-CD4 antibody and anti-CKR4 antibody (double-positive cells) were obtained for comparison. The differences between the TCA-treated and non-TCA-treated mucosae were analyzed by Mann-Whitney's U test.
RESULTS: Th2 cell infiltration was characteristically found just beneath the epithelium and in the periglandular areas. The mean count+/-standard deviation of Th2 cells was 4.96+/-2.72 cells/mm(2) in the TCA-treated mucosae and 12.03+/-7.19 cells/mm(2) in the non-treated mucosae, the difference being significant (p<0.01).
CONCLUSION: TCA treatment induces inhibition of Th2 cell infiltration. This corroborates the suggestion that TCA treatment can inhibit local type I allergic reactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010625     DOI: 10.1016/j.anl.2008.08.005

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  1 in total

1.  Cryosurgery Vs Trichloroacetic Acid Chemical Cautery for the Treatment of Hypertrophied Nasal Turbinate: A Comparative Study.

Authors:  Satish S Satpute; Samir V Joshi; Ripudaman Arora; Neel Prabha; Prashant Keche; Nitin M Nagarkar
Journal:  Iran J Otorhinolaryngol       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.